Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Ocular Therapeutix, Inc. (NASDAQ: OCUL)
OCUL Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-13.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
176.60%
OCUL Stock Analysis
OCUL
PE Ratio:
OCUL
PEG Ratio:
Not Available
OCUL
Forward EPS Growth (12 month):
0.00%
OCUL
PS Ratio:
35.1
OCUL
PSG Ratio:
Not Available
OCUL
Forward Revenue Growth (12 month):
0.00%
OCUL Articles
No data was found